Carmignac Gestion is supporting a campaign by UK-based activist fund Palliser Capital to try to improve corporate governance ...
LG Energy Solution (LGES) is reportedly preparing to replace cathode materials supplied by its parent company, LG Chem, in batteries destined for Tesla, opting instead for products from South Korean ...
Battery maker LG Energy Solution is reportedly planning to stop using cathode materials from its sister company LG Chem for batteries supplied to Tesla.
Opinion
1dOpinion
Palliser Seeks to Establish Minority Shareholder Voice at LG Chem as Company Continues to Ignore Deep Valuation Discount
The MarketWatch News Department was not involved in the creation of this content.-- Palliser Publishes "Recharge LG Chem" Presentation Ahead of March 31 General Meeting of Shareho ...
GM engineers say that the evolving relationship with LG Chem is what’s going to make the upcoming Bolt EV possible. 01-chevrolet-bolt-ev-concept-detroit-1-jpg Sebastian Blanco ...
EV battery fires are back in the news as Hurricane Helene batters the southeastern United States, submerging EVs and sending some of their batteries into thermal runaway. Between them and the Tesla ...
Palliser outlines opportunity for LG Chem to lead efforts to address the "Korea Discount" in letter to the Board of Directors. LONDON, February 09, 2026--(BUSINESS WIRE)--Palliser Capital ("Palliser") ...
South Korean-battery supplier LG Chem announced it has established a long-term cathode material supply contract with General Motors Co. that's worth $19 billion (KRW 25 trillion). Through the ...
Add Yahoo as a preferred source to see more of our stories on Google. LG Chem, Ravenna, Sept. 12. Ravenna City Council is moving forward with an electrical easement to help LG Chem to open its two ...
SEOUL (Reuters) -South Korea's LG Chem said on Wednesday it plans to sell 2 trillion Korean won ($1.43 billion) worth of shares in its battery unit LG Energy Solution to help improve finances and ...
AVEO Oncology, an LG Chem company, (AVEO) announced today that the 20mg/kg dose of ficlatuzumab was selected for the combination arm of the Phase 3 registrational FIERCE-HN clinical trial. This dose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results